Patent details
EP3448416 Title: SEMAGLUTIDE IN CARDIOVASCULAR CONDITIONS
Basic Information
- Publication number:
- EP3448416
- PCT Application Number:
- EP2017060160
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP177211091
- PCT Publication Number:
- WO2017186896
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SEMAGLUTIDE IN CARDIOVASCULAR CONDITIONS
- French Title of Invention:
- SEMAGLUTIDE DANS DES ÉTATS CARDIO-VASCULAIRES
- German Title of Invention:
- SEMAGLUTID BEI KARDIOVASKULÄREN STÖRUNGEN
- SPC Number:
Dates
- Filing date:
- 28/04/2017
- Grant date:
- 10/08/2022
- EP Publication Date:
- 06/03/2019
- PCT Publication Date:
- 02/11/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 10/08/2022
- EP B1 Publication Date:
- 10/08/2022
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 28/04/2023
- Expiration date:
- 28/04/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 03/08/2022
- Name:
- Novo Nordisk A/S
- Address:
- Novo Allé, 2880 Bagsværd, Denmark (DK)
Inventor
- Name:
- HANSEN, Oluf Kristian Højbjerg
- Address:
- Denmark (DK)
Priority
1
- Priority Number:
- 16167458
- Priority Date:
- 28/04/2016
- Priority Country:
- European Patent Office (EPO) (EP)
2
- Priority Number:
- 16188262
- Priority Date:
- 12/09/2016
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 38/26; A61P 3/10; A61P 9/00;
Publication
European Patent Bulletin
- Issue number:
- 202232
- Publication date:
- 10/08/2022
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|